Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
Fuji
Farmers Insurance
Daiichi Sankyo
US Department of Justice
McKesson
US Army

Generated: October 22, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: linagliptin

« Back to Dashboard

Linagliptin

CASRN: 668270-12-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Cipla
Harvard Business School
UBS
AstraZeneca
Teva
Johnson and Johnson
Medtronic